[{"NetIncomeLoss_1_Q2_USD":-33762000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":30387000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":15554000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37180000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":37257000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":42913000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":350000.0,"BilledContractReceivables_0_Q2_USD":30000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":750000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":1330000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":77300000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":77191000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":43000.0,"AssetsCurrent_0_Q2_USD":329082000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-373000.0,"DepreciationAndAmortization_2_Q2_USD":4126000.0,"AccountsReceivableNetNoncurrent_0_Q2_USD":3618000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":8093000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":4684000.0,"NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_2_Q2_USD":1123000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":42876000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":6534000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6534000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1825000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":3979000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":545000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":1330000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":7124000.0,"CommonStockSharesIssued_0_Q2_shares":37291000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":245018000.0,"Assets_0_Q2_USD":449738000.0,"ContractWithCustomerLiability_0_Q2_USD":4457000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":545000.0,"MarketableSecuritiesCurrent_0_Q2_USD":174964000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":1330000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-1355000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":75146000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":38111000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":43000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":3274000.0,"PrepaidExpenseCurrent_0_Q2_USD":9749000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-500000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-500000.0,"CommonStockValue_0_Q2_USD":4000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_Security":11.0,"InvestmentIncomeNet_2_Q2_USD":2536000.0,"InvestmentIncomeNet_1_Q2_USD":5722000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":3072000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":4586000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":43000.0,"CostsAndExpenses_1_Q2_USD":58399000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":146353000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":339200000.0,"OtherAssetsCurrent_0_Q2_USD":7271000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2_Q2_USD":600000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q2_USD":-1300000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-73255000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-32432000.0,"OtherAssetsNoncurrent_0_Q2_USD":4323000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":94222000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":7085000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":648729000.0,"Liabilities_0_Q2_USD":51877000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":545000.0,"CostsAndExpenses_2_Q2_USD":113743000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":1330000.0,"ShareBasedCompensation_2_Q2_USD":16333000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8635000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-251622000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":-500000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":-500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":24708000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2711000.0,"CommonStockSharesOutstanding_0_Q2_shares":37291000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":70665000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":18428000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":25659000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-74300000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-34262000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8316000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":16333000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-57069000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":15445000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":70054000.0,"AccountsPayableCurrent_0_Q2_USD":10901000.0,"NonoperatingIncomeExpense_2_Q2_USD":5233000.0,"NonoperatingIncomeExpense_1_Q2_USD":7571000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":95552000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":607000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3979000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":93000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":95552000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":607000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":42913000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_2_Q2_USD":7075000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":32696000.0,"NetIncomeLoss_2_Q2_USD":-73800000.0,"LiabilitiesCurrent_0_Q2_USD":40203000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":25424000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-1166000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-205000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccountsReceivableNet_0_Q2_USD":46494000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":4078000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":16566000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":34210000.0,"OperatingIncomeLoss_2_Q2_USD":-79533000.0,"OperatingIncomeLoss_1_Q2_USD":-41833000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":450000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":449738000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":9356000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":16333000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":219402000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7908000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":4007000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":397861000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":582000.0,"OtherOperatingIncomeExpenseNet_1_Q2_USD":-50000.0,"ProfitLoss_2_Q2_USD":-73800000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.98,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":1434000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3013000.0,"UnbilledContractsReceivable_0_Q2_USD":16500000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":51124000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":8316000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.91,"OtherOperatingIncomeExpenseNet_2_Q2_USD":-117000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]